Literature DB >> 2386204

C5a-induced neutrophilia. A primary humoral mechanism for recruitment of neutrophils.

T Kajita1, T E Hugli.   

Abstract

The leukocytosis activity of C5a was studied in a rabbit model. Blood samples were drawn for cell counts through a catheter placed in an artery of one rabbit ear after injection of either porcine or human C5a into a vein in the opposite ear. These studies indicate the potential of C5a to mobilize bone marrow neutrophils following transient C5a-induced neutropenia, based on counts of nonsegmented neutrophils. The numbers of circulating neutrophils can be selectively elevated by 300% to 400%, within 1 to 2 hours, in rabbits given only microgram quantities (1 to 5 x 10(-9) mol/l) of C5a or C5adesArg. These quantities of C5a are equivalent to 1% to 2% of complement C5 activation. The time-course of the induced neutrophilia is characteristic of C5a, increasing rapidly in the first 10 to 20 minutes after injection and attaining a maximum level at 2 to 5 hours, then decreasing slowly to normal levels over the next 4 to 6 hours. After boiling at 100 degrees C for 10 minutes, C5a (C5ades Arg) lost its leukocytosis activity, indicating that the cellular effect was not caused by endotoxin. Other known leukocytosis factors, such as epinephrine, dexamethasone, lipopolysaccharide, and the prostanoid 15(S)-15-methyl PGF2 alpha, produced a distinctly different profile of leukocyte mobilization than that of C5a. The C5a-induced neutrophilia was not inhibited by pretreating these animals with indomethacin, suggesting that it is not a prostanoid-induced effect. One hypothesis is that no secondary cellular mediator system is involved in C5a-mediated leukocytosis, but rather than C5a alone is responsible for a rapid mobilization of neutrophils from bone marrow pools, and perhaps marginated pools, following neutropenia. Circulating neutrophils are activated by C5a and thereby become deformed and adherent, leading to a neutropenia, sequestration, and depletion of cells. After the neutropenic event an immediate neutrophilic response is required for replacement of this particular cell population and to re-establish homeostasis. Therefore the role of C5a may be just as important as other known leukocytosis factors (fragments from C3, for example) in promoting complement-dependent neutrophil mobilization in response to tissue injury, infections, or extracorporeal blood treatments.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2386204      PMCID: PMC1877624     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects.

Authors:  J W ATHENS; O P HAAB; S O RAAB; A M MAUER; H ASHENBRUCKER; G E CARTWRIGHT; M M WINTROBE
Journal:  J Clin Invest       Date:  1961-06       Impact factor: 14.808

Review 2.  Characterization of receptors to the anaphylatoxins on isolated cells.

Authors:  Y Fukuoka; L P Nielsen; T E Hugli
Journal:  Dermatologica       Date:  1989

3.  The determination of the level of leukocytes in the blood stream with inflammation; a thermostable component concerned in the mechanism of leukocytosis.

Authors:  V MENKIN
Journal:  Blood       Date:  1949-12       Impact factor: 22.113

4.  Absence of induction of IL-1 production in human monocytes by complement fragments.

Authors:  W P Arend; R J Massoni; M A Niemann; P C Giclas
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

5.  Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries.

Authors:  G S Worthen; B Schwab; E L Elson; G P Downey
Journal:  Science       Date:  1989-07-14       Impact factor: 47.728

6.  Leukokinetic studies. 13. A non-steady-state kinetic evaluation of the mechanism of cortisone-induced granulocytosis.

Authors:  C R Bishop; J W Athens; D R Boggs; H R Warner; G E Cartwright; M M Wintrobe
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

7.  Neutrophilia-inducing activity in plasma of dogs recovering from drug-induced myelotoxicity.

Authors:  D R Boggs; G E Cartwright; M M Wintrobe
Journal:  Am J Physiol       Date:  1966-07

8.  The contributions of adrenal hormones, hemodynamic factors, and the endotoxin-related stress reaction to stable prostaglandin analog-induced peripheral lymphopenia and neutrophilia.

Authors:  T R Ulich; M Keys; R X Ni; J del Castillo; E B Dakay
Journal:  J Leukoc Biol       Date:  1988-01       Impact factor: 4.962

9.  Comparison of in vivo effects of intravenous infusion of N-formyl-methionyl-leucyl-phenylalanine and phorbol myristate acetate in rabbits.

Authors:  J E Lafuze; M D Baker; A L Oakes; R L Baehner
Journal:  Inflammation       Date:  1987-12       Impact factor: 4.092

10.  Transient adhesion of neutrophils to endothelium.

Authors:  S K Lo; P A Detmers; S M Levin; S D Wright
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  9 in total

1.  Complement activation promotes muscle inflammation during modified muscle use.

Authors:  J Frenette; B Cai; J G Tidball
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

Review 2.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

3.  T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?

Authors:  Florian Anzengruber; Pinar Avci; Lucas Freitas de Freitas; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2015-06-11       Impact factor: 3.982

4.  Cloning and preliminary pharmacological characterization of the anaphylatoxin C5a receptor in the rabbit.

Authors:  D R Bachvarov; S Houle; M Bachvarova; J Bouthillier; S A St-Pierre; Y Fukuoka; J A Ember; F Marceau
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 5.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

6.  Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium.

Authors:  A Väkevä; B P Morgan; I Tikkanen; K Helin; P Laurila; S Meri
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

7.  Complement inhibition by soluble complement receptor type 1 fails to moderate cerulein-induced pancreatitis in the rat.

Authors:  M R Weiser; S A Gibbs; F D Moore; H B Hechtman
Journal:  Int J Pancreatol       Date:  1996-04

8.  Effects of anti-inflammatory drugs on fever and neutrophilia induced by Clostridium difficile toxin B.

Authors:  R A Cardoso; A A Filho; M C Melo; D M Lyerly; T D Wilkins; A A Lima; R A Ribeiro; G E Souza
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

Review 9.  Diverse Localization and Protein Binding Abilities of Glyceraldehyde-3-Phosphate Dehydrogenase in Pathogenic Bacteria: The Key to its Multifunctionality?

Authors:  Monika Kopeckova; Ivona Pavkova; Jiri Stulik
Journal:  Front Cell Infect Microbiol       Date:  2020-03-03       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.